HER2 Support Group Forums - View Single Post

07-12-2005, 02:48 PM

I may be beating this drum too often, but I do think this group of people IS large enough to be worth a clinical trial since the oncs clearly don't have a consensus (i.e., they just don't KNOW enough to say).

Patients and oncs working in this category are going at it hit or miss and have to stumble around as best we can, and at the end of all this effort and expense there will be no data to learn from.

I believe there are years and years of currently NED HER2's who were treated with either CMF, CEF, CAF, or AC without getting Herceptin, and who would be willing to consider participating in a clinical trial where some would get a taxane with Herceptin and some with just Herceptin.

I will try a poll, to see what the level of interest might be.

AlaskaAngel

07-12-2005, 02:48 PM	#14
AlaskaAngel Guest Posts: n/a	I may be beating this drum too often, but I do think this group of people IS large enough to be worth a clinical trial since the oncs clearly don't have a consensus (i.e., they just don't KNOW enough to say). Patients and oncs working in this category are going at it hit or miss and have to stumble around as best we can, and at the end of all this effort and expense there will be no data to learn from. I believe there are years and years of currently NED HER2's who were treated with either CMF, CEF, CAF, or AC without getting Herceptin, and who would be willing to consider participating in a clinical trial where some would get a taxane with Herceptin and some with just Herceptin. I will try a poll, to see what the level of interest might be. AlaskaAngel